Ligand validation:3ZSX

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZSX_EDO_A_1213	49%	59%	0.153	0.899	0.48	1.08	-	-	2	0	100%	1
3ZSX_EDO_B_1215	28%	66%	0.217	0.868	0.43	0.86	-	-	0	0	100%	1
4AHT_EDO_B_1216	96%	73%	0.067	0.975	0.5	0.55	-	-	0	0	100%	1
4AHS_EDO_B_1217	78%	66%	0.09	0.931	0.27	1.01	-	-	2	0	100%	1
4CEB_EDO_B_1213	3%	75%	0.191	0.534	0.62	0.36	-	-	4	0	100%	1
3ZSV_EDO_B_1213	3%	75%	0.191	0.533	0.62	0.36	-	-	4	0	100%	1
5HRS_EDO_A_305	3%	74%	0.266	0.605	0.87	0.17	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.